ATXN2 and amyotrophic lateral sclerosis: The ALS clinic at Montreal's Neurological Institute Hospital (The Neuro), a leading provider of genetic testing for newly diagnosed ALS patients, incorporated the ATXN2 test into their offerings in October 2020 [71].